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Abstract 
Binding of mouse erythrocytes oxidized in vitro mildly with diamide, periodate or ADP/Fe 3+, and the erythrocytes incubated in vitro 
in a serum-free medium for 12 h (in vitro aged erythrocytes) to mouse peritoneal macrophages was effectively inhibited by isolated 
glycophorin A, a major sialoglycoprotein of human erythrocyte membrane existing as oligomers in solution, and some of known ligands 
for macrophage scavenger receptors uch as maleyl-BSA, dextran sulfate, fucoidan and polyinosinic acid. Binding of oxidized low 
density lipoprotein (ox-LDL) to macrophages was inhibited by glycophorin A as well as the known ligands. When the sialyl residues of 
the saccharide chains of glycophorin A were cleaved by neuraminidase, or the polypeptide of glycophorin A was digested by Pronase, 
which would destroy its oligomeric forms, the inhibitory effect of glycophorin A was decreased, suggesting that isolated glycophorin A
binds to scavenger receptors depending on its sialyl residues and oligomeric structure. Glycopeptides prepared from the N-terminal region 
of glycophorin A containing most of the sialosaccharide chains of the molecule inhibited the binding of ox-LDL although the potency was 
lower than that of glycophorin A. N-Acetylneuraminic a id at a high concentration also inhibited the ox-LDL binding. Uptake and 
degradation of t25I-labeled ox-LDL by macrophages was inhibited by glycophorin A, N-acetylneuramin lactose, as well as the known 
ligands. 125I-labeled glycophorin A bound to macrophages, and the binding was inhibited by the unlabeled glycophorin A and the known 
ligands. Inhibitory activity of the unlabeled glycophorin A against the labeled glycophorin A-binding was lowered by neuraminidase and 
Pronase treatment. These results suggest that oxidized and in vitro aged mouse erythrocytes are recognized by scavenger receptors of 
mouse peritoneal macrophages, and the cell surface components recognized are sialosaccharide chains of glycophorin, possibly 
glycophorin A counterpart of mouse erythrocytes which clustered or aggregated in the membrane. The finding indicates that the cell 
surface sialosaccharides can be ligands for scavenger receptors when cells undergo denaturation by oxidative stress or other damaging 
effects. 
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1. Introduction 
Selective recognition-and-removal of damaged or effete 
components and cells is one of the important functions of 
macrophages for maintenance of homeostasis [ 1,2]. One of 
the possible causes of the in vivo damage is oxidative 
stress [3]. In living tissue, active oxygens such as superox- 
ide anion (O2), hydrogen peroxide (H202), and hydroxyl 
Abbreviations: BSA, bovine serum albumin; DPBS, Dulbecco's phos- 
phate-buffered saline; DPBS(-), Ca 2 +- and Mg 2 +-free Dulbecco's phos- 
phate buffered-saline; Hepes, N-2-hydroxyethylpiperazine N'-2-ethane 
sulfonic acid; LDL, low density lipoprotein; ox-LDL, oxidized low 
density lipoprotein; Maleyl-BSA, maleylated BSA; TCA, trichloroacetic 
acid. 
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radical (. OH) can cause free radical damage of various 
components, including lipids and proteins, when oxidative 
stress exceeds the ability of the antioxidant protection 
[4-8]. 
Our previous studies have shown that mouse erythro- 
cytes oxidized in vitro mildly with oxidizing agents such 
as diamide [9,10], periodate [9,10], and ADP-chelated fer- 
ric ion (ADP/Fe  3+) [11,12] are recognized by mouse 
peritoneal resident or thioglycollate-induced macrophages 
in the absence of opsonizing antibodies. In these studies, 
the binding of oxidized erythrocytes to macrophages i  
caused by oxidation of SH groups of membrane proteins, 
and prevented by reduction of disulfides [9,12]. Further- 
more, the binding to the resident macrophages i  inhibited 
by glycophorin A, a major sialoglycoprotein of human 
erythrocytes, and ganglioside GDIa, depending on their 
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sialyl residues [10,12]. It is suggested that resident peri- 
toneal macrophages recognized the oxidized erythrocytes 
through recognition of sialosaccharide chains of the mem- 
brane glycoconjugates, most likely those of glycophorin, 
that underwent lateral redistribution (like clustering or 
aggregation) in the membrane by the membrane protein 
oxidation [10,12]. The macrophage membrane component 
having affinity for sialosaccharides appears to be involved 
in the recognition of the oxidized erythrocytes [ 10,12]. 
Macrophages have been shown to express receptors or 
adhesion molecules with sialosaccharide-binding activity 
such as sialoadhesin [ 13-15] and L-selectin [ 16-18]. These 
two molecules are, however, unlikely to be involved in the 
recognition of the oxidized erythrocytes because siaload- 
hesin is expressed on stromal tissue macrophages but is 
poorly expressed on peritoneal macrophages [13], and the 
fucosyl residue that is required for the ligands of L-selectin 
[18] is not necessary for the recognition of oxidized ery- 
throcytes by peritoneal macrophages [ 10,12]. 
Another potential candidate for the receptor involved in 
the recognition is scavenger receptors. Scavenger receptors 
are a group of the macrophage r ceptors that selectively 
bind and take up chemically modified low density lipopro- 
tein (LDL) such as oxidized LDL (ox-LDL) [19,20], acety- 
lated LDL [21,22], and malonaldehyde-modified LDL 
[22,23]. Excessive uptake of the modified LDL by 
macrophages in culture results in accumulation of lipid 
droplets characteristic to the macrophage-derived lipid- 
laden foam cells found in early atherosclerotic lesions 
[20-24]. Lines of evidence suggest occurrence of ox-LDL 
in vivo [25-27], and the formation of foam cells by uptake 
of ox-LDL through scavenger receptors has been hypoth- 
esized to be an initial step in the formation of athero- 
sclerotic lesions [20,28]. Scavenger receptors exhibit broad 
binding specificity for various polyanionic macro- 
molecules or macromolecular complexes [22,24,29]. In 
addition to the modified LDL, they bind maleylated bovine 
serum albumin (maleyl-BSA) [21,22], dextran sulfate 
[22,24], fucoidan [22,24], polyinosinic acid (poly I) [22,24] 
and polyguanylic acid (poly G) [22,24]. They also bind 
phosphatidylserine-containing liposomes [30] and bacterial 
lipopolysaccharide [31]. However, polyanionic molecules 
such as polyadenylic acid (poly A), polycytidylic acid 
(poly C) and colominic acid, a homopolymer of N- 
acetylneuraminic acid, are not ligands for scavenger recep- 
tors [22,24,29], indicating that polyanionic property is not 
enough to be a ligand. 
In the present report, we show that the receptors of 
mouse peritoneal macrophages involved in the recognition 
of the mouse erythrocytes mildly oxidized with diamide, 
periodate and ADP/Fe 3+ are scavenger receptors, and the 
ligands on the oxidized erythrocytes recognized by scav- 
enger receptors are sialosaccharide chains of glycophorin. 
To our knowledge, this is the first example indicating that 
cell surface saccharide chains are recognized by scavenger 
receptors. 
2. Materials and methods 
2.1. Materials 
ADP monopotassium salt was obtained from Oriental 
Yeast. Diazene dicarboxylic acid bis(N,N'- 
dimethylamide)(diamide), D-glucose, N-acetylneuraminic 
acid, N-acetyl-D-galactosamine, N-acetylneuramin lactose 
(a mixture of N-acetylneuraminyl-~2-3-1actose (67%), N- 
acetylneuraminyl-c~2-6-1actose (16%), and N- 
acetylneuraminyl-c~ 2-6-N-acetyllactosamine (17%)), 
bovine fetuin, human c~-acid glycoprotein, bovine serum 
albumin (essentially globulin-free) (BSA), dextran sulfate, 
fucoidan, colominic acid, polycytidylic acid (poly C), poly- 
inosinic acid (poly I), polyadenylic acid (poly A) and 
trypsin (from bovine pancreas, N-tosyl-L-phenylalanine 
chloromethylketone(TPCK)-treated) were purchased from 
Sigma. Sodium metaperiodate, D-galactose, D-mannose, L- 
fucose, lactose and maleic anhydride were obtained from 
Wako Pure Chemical Industries. N-Acetyl-D-glucosamine, 
bovine submaxillary mucin, Pronase (Actinase E), neu- 
raminidase (Vibrio cholerae) (EC 3.2.1.18), RPMI 1640 
medium and fetal calf serum, and N-2-hydroxyethyl- 
piperazine N'-2-ethane sulfonic acid (Hepes) were ob- 
tained from Tokyo Kasei Kogyo, Worthington, Kaken 
Seiyaku, Behringwerke AG, GIBCO Laboratories, and Do- 
hjin Chemical Laboratories, respectively. Na~2SI was ob- 
tained from ICN Biomedical. 
2.2. Analyses 
Protein was determined according to the method of 
Lowry et al. [32] using BSA as a reference standard. Sialic 
acid content of glycoprotein was determined by the War- 
ren method [33] after mild acid hydrolysis. 
2.3. Maleylated BSA (maleyl-BSA) 
MaleyI-BSA was prepared according to the method of 
Butler and Hartley [34] as described previously [35]. Ap- 
proximately 95% of total amino groups of BSA were 
blocked by maleyl groups as determined by the trinitroben- 
zenesulfonic acid method of Habeeb [36]. 
2.4. Low density lipoprotein (LDL) and oxidized LDL 
(ox-LDL) 
LDL was isolated from human plasma according to the 
ultracentrifugation method of Hatch and Lees [37] with 
minor modifications as described previously [38]. LDL 
fraction obtained was dialyzed against 10 mM phosphate- 
buffered saline (pH 7.4) at 4 ° C, and subjected to Cu 2÷- 
catalyzed oxidation according to the method of Stein- 
brecher et al. [39] to obtain ox-LDL. In brief, the LDL 
solution at 2 mg protein/ml was incubated with 5 /zM 
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CuSO 4 at 37 ° C for 24 h. After addition of butylhydroxy- 
toluene at 0.05 mM, the solution was dialyzed against he 
nitrogen gas-treated saline and centrifuged to remove a 
small amount of precipitate, and stored at 4 ° C until re- 
quired. 
2.5. Glycophorins 
Sialoglycoprotein fraction was isolated from human 
erythrocyte ghosts according to the method of Marchesi 
and Andrews [40]. The fraction was separated into gly- 
cophorin A and glycophorins B + C using a Sepharose 6B 
column according to the method of Furthmayr [41,42]. The 
glycophorin preparations were extensively dialyzed against 
water and lyophilized. Sialic acid contents of glycophorin 
A and glycophorins B + C were 17.4 and 30.1%, respec- 
tively. 
2.6. T1 + T2 tryptic glycopeptides of glycophorin A
T1 + T2 tryptic glycopeptides of glycophorin A were 
isolated according to the method of Tomita et al. [43]. In 
brief, a solution of purified glycophorin A (10 mg) with a 
small amount of 125I-glycophorin A in 1 ml of 50 mM 
Tris-HCl (pH 8.5) containing 1 mM CaC12 was mixed 
with 0.1 ml of a solution of TCPK-treated trypsin (3.3 
mg/ml)  in the same buffer. The mixture was incubated at 
37 ° C for 24 h, and 2 /xl of a solution of 0.2 M phenyl- 
methylsulfonyl fluoride in ethanol was added to the mix- 
ture, and the mixture was incubated at 37 ° C for additional 
1 h to inactivate the enzyme. The pH of the mixture was 
made to 3.5 by addition of 2 ml of 5 M acetate buffer (pH 
3.5), and the mixture was kept at 4 ° C. The precipitated 
lipophilic T6 tryptic peptide was removed by centrifuga- 
tion at 18 600 X g for 20 min. The supernatant was applied 
to a column (2.5. 146 cm) of Sephadex G-50 superfine 
equilibrated with 0.1 M ammonium acetate buffer (pH 
6.8). As estimated by the radioactivity, T1 + T2 peptides, 
T3 + T4 peptides and T5 pepteide were eluted in this order 
[43]. Glycophorin A which should be eluted at the void 
volume of the column wa,; completely lost. T1 + T2 pep- 
tides were collected and lyophilized for use (3.6 mg). 
2.7. Enzymatic treatment of glycophorin A and T1 + T2 
tryptic glycopeptides 
Glycophorin A (1.0 mg/ml),  or T1 + T2 tryptic gly- 
copeptides (2.0 mg/ml)  was incubated with neuraminidase 
(100 mU/ml)  or Pronase (0.5 mg/ml)  at 37 ° C for 96 h in 
Dulbecco's phosphate-buffered saline (DPBS) containing a
drop of chloroform. The mixture was heated at 100 ° C for 
5 min in order to destroy the enzyme activity. Measure- 
ment of free sialic acid of neuraminidase-treated gly- 
cophorin A indicated that 100% of sialic acid was released. 
2.8. Mouse erythrocytes 
Erythrocytes were obtained from Balb/c mice. Blood 
was collected by cardiac puncture using acid citrate-dex- 
trose preservative solution, and erythrocytes were cen- 
trifuged down (320 × g, 10 min) to remove the buffy coats 
and plasma, and washed three times with Ca 2+- and 
Mg2+-free DPBS (DPBS ( - ) )  by centrifugation at650 × g 
for 5 min. 
2.9. Ox-LDL-coated mouse erythrocytes 
The coating was carried out as described previously 
[35]. One volume of a 2.5% erythrocyte suspension in 
saline was mixed with 0.25 volume of a solution of native 
LDL or ox-LDL in saline (50 /xg protein/ml) giving a 
final concentration of 10 /xg/ml, and the mixture was 
incubated at 37 ° C for 15 min with occasional mixing. The 
mixture was then diluted with an equal volume of ice-cold 
DPBS ( - )  and centrifuged at 170 X g for 15 min at 4°C. 
The cell pellet was washed twice with the same buffer by 
centrigugation, and resuspended in RPMI 1640 medium 
containing 20 mM Hepes (pH 7.2), 50 units/ml of peni- 
cillin and 50 /zg/ml of streptomycin (RPMI-Hepes 
medium) to make a 2% cell suspension. The cell suspen- 
sion was prepared on the day of use. 
2.10. Mouse peritoneal macrophages 
Mouse resident peritoneal macrophages were obtained 
from the peritoneal cavity of 8- to 12-week-old Balb/c 
male mice for binding experiments of oxidized erythro- 
cytes, in vitro aged erythrocytes, and ox-LDL-coated ery- 
throcytes, and ddY male mice for other experiments. The 
cells were washed with RPMI-Hepes medium at 4 ° C by 
centrifugation at 80 X g for 10 min, and resuspended in
the same medium for use. A macrophage monolayer was 
prepared as follows. The cell suspension (0.2 ml) of 2 • 10  6 
cells/ml was loaded onto a round glass coverslip (18-mm 
diameter, 0.15-0.18 mm thick), or the cell suspension (1 
ml) of 1 • 106 cells/ml was placed into a well of a 24-well 
plastic plate (16 mm diameter). After incubation at 37°C 
for 1 h, non-adherent cells were removed by washing three 
times with DPBS(- ) .  The monolayer cells were cultured 
in RPMI 1640 medium containing 10% fetal calf serum at 
37°C overnight in a CO 2 incubator (5% CO:). The cells 
were washed with DPBS( -  ) for use. 
The number of monolayer macrophages was determined 
by the amount of cell proteins. Macrophage monolayers 
were prepared as described above on 60-mm plastic cul- 
ture dishes. The monolayer cells were lysed with 0.2 M 
NaOH and the amount of protein in the lysate was deter- 
mined. The value of cell-free dishes was subtracted as a 
blank. The equivalent monolayer macrophages were 
scraped from the dish in 3 ml of DPBS( - )  containing 
0.5% BSA and 1 mM EDTA, dispersed, and the number of 
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the cells was counted. Usually 1 mg protein corresponded 
to 1 • 10  7 macrophages. 
2.11. Oxidized mouse erythrocytes 
Oxidation of mouse erythrocytes with diamide was 
carried out as described [9,10]. Thus, a 10% suspension of 
mouse erythroyctes in 12.5 mM sodium phosphate buffer 
(pH 8.0) containing 0.1 M KC1, 50 mM NaC1, and 44 mM 
sucrose was treated with 1 mM diamide at 37°C for 30 
min. Oxidation with periodate was performed as described 
[9,10,44]. Thus a 10% suspension of the cells in 10 mM 
acetate buffer (pH 6.0) containing 0.14 M NaC1 was 
treated with 1 mM sodium metaperiodate at 0°C for 15 
min. After the treatment the cells were recovered by 
centrifugation at 170 × g for 15 min, and washed three 
times with DPBS ( - ) .  Oxidation with ADP/Fe 3+ was 
performed as described [11,12]. Thus a 20% suspension of 
the cells in DPBS was treated with ADP/Fe 3+ (1.7/0.1 
mM) at 37°C for 1 h. The oxidized erythrocytes were 
resuspended in RPMI-Hepes medium containing 1% BSA 
to make a 2% cell suspension for use. 
2.12. In vitro aged erythrocytes 
A 20% cell suspension of mouse erythrocytes in Eagle's 
minimum essential medium containing 20 mM Hepes (pH 
7.2) were incubated at 37°C for 12 h with gentle shaking. 
The cells were pelleted by centrifugation, washed twice 
with DPBS(-) ,  resuspended in RPMI-Hepes medium to 
make a 2% cell suspension, and used as in vitro aged 
erythrocytes. The 12-h incubation of mouse erythrocytes 
resulted in hemolysis of 1-8% of total cells as determined 
by the concentration f hemoglobin released into the incu- 
bation medium. 
2.13. Binding of oxidized erythrocytes, in vitro aged ery- 
throcytes, and ox-LDL-coated erythrocytes tomacrophages 
Binding of erythrocytes to the macrophage monolayers 
was performed as described previously [9,10,12]. Thus, a 
2% erythrocyte suspension (200 /xl) was loaded on the 
macrophage monolayer on a coverslip, and incubated at 
37°C for 1 h for oxidized erythrocytes and in vitro aged 
erythrocytes, and for 30 min for ox-LDL-coated erythro- 
cytes. Non-adherent erythrocytes were removed by gentle 
washing with DPBS(-  ). After fixing the cells with 1.25% 
glutaraldehyde, the percentage of macrophages binding 
two or more erythrocytes on their surface was determined 
under phase-contrast microscopy. More than 200 
macrophages were counted for one determination. For 
inhibition of the binding of oxidized erythrocytes and in 
vitro aged erythrocytes to the macrophage monolayer, the 
monolayer was incubated with the erythrocyte suspension 
containing the competitor at 37°C for 1 h, and processed 
as described above. For inhibition of the binding of ox- 
LDL-coated erythrocytes, the monolayer was preincubated 
with the competitor at 37°C for 1 h, and then with the 
erythrocyte suspension containing the same competitor at 
37°C for 30 min, and processed as described above. The 
data for the inhibition studies were expressed as % of 
control assay, where macrophage binding in the absence of 
competitors was taken as 100. 
2.14. Degradation of t25I-ox-LDL by macrophages 
~25I-Labeling of LDL and ox-LDL was performed ac- 
cording to the iodine monochloride method [45] using 
glycine-NaOH buffer (pH 10) as described. To 0.5 ml of a 
solution of LDL (2 mg protein/ml), 0.2 mCi of a solution 
of Na125I in 0.2 M phosphate buffer (pH 7.4) (1 mCi/100 
/xl), 100/zl of a solution of 1 M glycine-NaOH buffer (pH 
10.0) and 125/zl of a solution of 0.4 mM IC1 in 2 M NaC1 
were added in this order under stirring. The mixture was 
immediately passed through a column (0.9.22 cm) of 
Sephadex G-50 equilibrated with DPBS(-) .  The fractions 
eluted at the void volume of the column were collected 
and dialyzed overnight against 0.15 M NaC1/0.3 mM 
EDTA (pH 7.4) to remove contaminating low-moleocular- 
weight radioactive materials. 125I-LDL and 125I-ox-LDL 
with specific activity of 200000 cpm//zg protein were 
usually obtained. 
~25I-ox-LDL uptake and its proteolytic degradation by 
the cells was measured by assaying the amount of 125I- 
labeled trichloroacetic a id (TCA)-soluble material formed 
by the cells and excreted into the medium [46]. A mono- 
layer of mouse peritoneal macrophages in a well of a 
24-well plastic plate was incubated with 0.5 ml of 125I-ox- 
LDL (10 /zg/ml) in RPMI-Hepes medium in the absence 
or the presence of the inhibitor at 37°C for 5 h. The 
medium (0.5 ml) was recovered and the radioactivity in the 
10% TCA-soluble supernatant of the medium was mea- 
sured. A control experiment without macrophages showed 
that more than 95% of the radioactivity was precipitated 
under the conditions. 
2.15. Binding of 1251-glycophorin A and the 125I-T1 q- T2 
tryptic glycopeptides tomacrophages 
125I-Labeling of glycophorin A and its T1 + T2 tryptic 
glycopeptides was performed by the iodine monochloride 
method as described above. ~25I-Glycophorin A and ~25I- 
glycopeptides prepared showed specific activity of 100 000 
and 22 000 cpm//xg, respectively. 
A monolayer of macrophages in a well was incubated 
with the indicated concentration f ~25I-glycophorin A (0.5 
ml) or 125I-T1 + T2 tryptic glycopeptides (0.5 ml) in 
RPMI-Hepes medium in the absence or the presence of the 
competitor at 37°C for 2 h. The cells were washed four 
times with DPBS( - )  and lysed with 0.2 M NaOH. The 
radioactivity of the lysate was measured. The radioactivity 
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obtained in control experiments without the cells was 
subtracted. 
3. Results 
3.1. Inhibition of the binding of oxidized and in vitro aged 
mouse erythrocytes to mouse peritoneal macrophages by 
glycophorin A and the ligands for scavenger receptors 
Mouse erythrocytes were treated with 1 mM diamide at 
37°C for 30 min. By this treatment, membrane and cyto- 
plasmic SH groups are decreased to produce disulfide-de- 
pendent cross-linking of membrane proteins without ac- 
companying significant lipid peroxidation [9,10]. It has 
been shown that the oxidized cells bind to mouse peri- 
toneal macrophages [9] and the binding is effectively 
inhibited by glycophorin A, a major sialoglycoprotein of 
human erythrocyte membrane, and also by N- 
acetylneuramin lactose [10]. Inhibitory effect of known 
ligands and non-ligands for scavenger receptors on the 
binding was investigated in order to know whether scav- 
enger eceptors are involved in the binding (Table 1). The 
binding was inhibited by the scavenger receptor ligands, 
maleyl-BSA, fucoidan anti poly I, although only slightly 
inhibited by another ligand dextran sulfate. The binding 
was not inhibited by the non-ligands, BSA and poly A. 
Mouse erythrocytes were treated with 1 mM sodium 
metaperiodate at 0 ° C for i15 min. This treatment results in 
the oxidative degradation of sialyl residues of the mem- 
brane glycoproteins, lipid peroxidation and SH-oxidation 
[44]. The oxidized cells bind to mouse peritoneal 
macrophages [9] and the binding is inhibited by gly- 
cophorin A and also by N-acetylneuraminic a id [10]. 
Inhibitory effect of the ligands and the non-ligands for 
scavenger receptors on the binding was investigated (Table 
1). The binding was inhibited by the ligands, maleyl-BSA, 
dextran sulfate, fucoidan and poly I, and not by the 
non-ligands, BSA, poly A, poly C and colominic acid. 
Mouse erythrocytes were treated with ADP/Fe 3+ 
(1.7/0.1 mM) at 37°C for 1 h. By this treatment, slight 
lipid peroxidation and membrane protein SH-oxidation are 
induced [11,12] without any accompanying physico- 
chemical change of the cells. The oxidized cells bind to 
mouse peritoneal macrophages and the binding is effec- 
tively inhibited by glycophorin A, N-acetylneuramin lac- 
tose and N-acetylneuraminic acid [12]. Inhibitory effect of 
the ligands and the non-ligands for scavenger receptors on 
the binding was investigated (Table 1). The binding was 
inhibited by the ligands, dextran sulfate, fucoidan and poly 
I, but only weakly or little by the non-ligands, poly A, poly 
C and colominic acid. 
In the previous studies [10,12], we noticed that the 
susceptibility of mouse erythrocytes to the macrophage 
recognition slightly increased when erythrocytes were in- 
cubated in vitro in DPBS at 37°C for 1 h, and the 
recognition was inhibited by glycophorin A but not by 
glycophorin A whose sialyl residues at the terminal of the 
saccharide chains had been hydrolysed by neuraminidase. 
This observation suggests that erythrocytes incubated in 
vitro undergo membrane change similar to that of oxidized 
cells. Whether the macrophage r cognition of such cells is 
Table 1 
Inhibition of the binding of variously oxidized mouse erythroyctes to mouse peritoneal macrophages by glycophorin A and known ligands for scavenger 
receptors 
Competitor Macrophage binding (% of control assay) 
Diamide-treated Periodate-treated ADP/Fe 3 + -treated 
erythrocytes erythrocytes erythrocytes 
(mg/ml) 
None 100 
A. Glycophorin A 0.1 3.3 + 1.3 a 
B. Ligand for scavenger receptors 
Maleyl-BSA 1.0 5.6 --I- 1.0 
Dextran sulfate 0.1 79.1 ± 7.3 
Fucoidan 0.1 6.9 + 2.1 
Poly I 0.1 16.3 + 2.9 
C. Non-ligand for scavenger receptors 
BSA 1.0 96.7 ± 3.7 
Poly A 0.1 94.8 + 13.1 
Poly C 0.1 
Colominic acid 0.1 
100 
44.3 + 7.7 a 
1.1+ 0.6 
38.0 + 2.4 
1.4 + 1.0 
3.6 + 1.2 
100 
18.6 + 6.5 b 
13.6 + 4.4 
34.6 -t- 10.4 
28.1 + 13.4 
116.4 ± 8.0 
101.6 + 12.3 72.1 ± 7.9 
93.4 + 4.4 91.7 + 7.0 
111.9 + 8.0 96.9 + 7.0 
A monolayer of mouse peritoneal macrophages was incubated with oxidized mouse erythrocytes in the presence of the indicated concentrations of
glycophorin A or the ligands for scavenger receptors at 37 ° C for 1 h. In the absence of the competitors (control assay, 'none' in the table), usually 
68-83% of total macrophages bound the diamide-treated cells, 30-40% bound the ADP/Fe 3 +-treated cells, 62-74% bound the periodate-treated cells, and 
5-15% bound the unoxidized control cells. Values given are the means + S.D. of triplicate coverslips. 
a Data from Ref. [10]. 
b Data from Ref. [12]. 
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Table 2 
Inhibition of the binding of in vitro aged mouse erythrocytes to mouse 
peritoneal macrophages by sialic acid, glycophorin A and known ligands 
for scavenger receptors 
Competitor Macrophage binding 
(% of control assay) 
None 100 
A. Monosaccharide (mM) 
D-Glucose 50 92.7 + 7.5 
o-Galactose 50 98.8 _ 25.8 
D-Mannose 50 112.0+ 5.0 
L-Fucose 50 101.5 + 0.3 
N-Acetyl-D-glucosamine 50 110.2+ 9.7 
N-Acetyl-o-galactosamine 50 107.6 + 21.2 
N-Acetylneuraminic a id ~ 50 49.0 + 10.3 
D-Glucronic acid a 50 105.7 + 13.9 
B. Sialoglycoprotein (mg/ml) 
Glycophorin A 0.01 78.8+ 4.8 
0.1 4.6+ 1.8 
Glycophorin A (control) b 0.1 48.0 + 6.8 
(neuraminidase-treated) 0.1 87.5 ± 13.9 
oq-Acid glycoprotein 0.1 89.5 + 13.9 
Fetuin 0.1 84.0 + 14.2 
Bovine submaxillary mucin 0.1 72.8+ 4.9 
C. Ligand for sca~,enger receptors 
Maleyl BSA 
Dextran sulfate 
Poly I 
D. Non-ligand for scaL'enger receptors 
BSA 
Poly C 
1.0 50.3 + 4.0 
0.1 36.2+ 6.9 
0.1 8.1 + 3.0 
1.0 104.6+ 7.7 
0.1 76.6+ 10.2 
A monolayer of mouse peritoneal macrophages was incubated with 
mouse rythrocytes preincubated in serum-free medium at 37 ° C for 12 h 
(in vitro aged erythrocytes) in the presence of the indicated concentra- 
tions of monosaccharides, sialoglycoproteins, or the ligands for scavenger 
receptors at 37°C for 1 h. In the absence of the competitors (control 
assay, 'none' in the table), usually 54-75% of total macrophages bound 
the in vitro aged cells, and 4-13% of total macrophages bound unincu- 
bated intact cells. Values given are the means + S.D. of triplicate cover- 
slips. 
a Solution neutralized. 
b Similarly processed to the neuraminidase-treated glycophorin A without 
the enzyme. 
mediated by scavenger receptors was investigated using 
mouse erythrocytes incubated in serum-free medium at 
37 ° C for 12 h (in vitro aged erythrocytes). 
Mouse peritoneal macrophages bound (57.1 + 7.8%) 
and phagocytosed (16.7 + 2.5%) the in vitro aged erythro- 
cytes, while only 10.1 +5.1% and 1.2__+0.6% of the 
macrophages bound and phagocytosed unincubated intact 
cells, respectively. As shown in Table 2, binding of in 
vitro aged mouse erythrocytes to mouse peritoneal 
macrophages was moderately or strongly inhibited by N- 
acetylneuraminic acid, glycophorin A, and the ligands for 
scavenger receptors (maleyl-BSA, dextran sulfate and poly 
I), while only weakly or not by other monosaccharides and 
glycoproteins (ce 1- acid glycoprotein, fetuin, and bovine 
submaxillary mucin), and non-ligands BSA and poly C. 
Neuraminidase treatment of glycophorin A resulted in the 
loss of the inhibitory activity (Table 2). 
These competitive inhibition studies using the known 
ligands and non-ligands for scavenger receptors howed 
that the binding of variously oxidized mouse erythrocytes 
and in vitro aged mouse erythrocytes to mouse peritoneal 
macrophages was mediated by scavenger receptors. More- 
over, the results suggest hat the ligands on the erythro- 
cytes for scavenger receptors are the sialosaccharide chains 
of glycophorin, possibly glycophorin A counterpart of 
mouse erythrocytes. 
3.2. Inhibition of binding and degradation of ox-LDL by 
mouse peritoneal macrophages byglycophorin A 
To clarify whether glycophorin A is a ligand for scav- 
enger receptors, we then undertook competitive inhibition 
studies of macrophage binding and uptake of ox-LDL 
using glycophorin A. 
Binding of ox-LDL to mouse peritoneal macrophages 
was measured according to the previously devised method 
[35]. In this method, binding of ox-LDL is assessed as the 
adherence of mouse erythrocytes coated with ox-LDL to 
the macrophage monolayer, and the degree of the adher- 
ence is expressed as the proportion of the macrophages 
binding ox-LDL-coated erythrocytes. Usually 30-45% of 
mouse peritoneal macrophages bind the ox-LDL-coated 
erythrocytes, while only 2-3% of the macrophages bind 
native LDL-coated erythrocytes. The binding of ox-LDL- 
coated erythrocytes i scavenger receptor-specific since 
their binding is inhibited by the ligands for scavenger 
receptors uch as ox-LDL, maleyl-BSA, dextran sulfate, 
fucoidan and poly I, but not by the non-ligands uch as 
BSA and poly C [35]. 
Inhibitory effect of various sialoglycoproteins against 
the binding of ox-LDL-coated erythrocytes to macrophages 
was examined. The results shown in Table 3 (section A) 
indicate that glycophorin A had the potent inhibitory activ- 
ity, and glycophorins B + C had moderate activity, whereas 
c~-acid glycoprotein and bovine submaxillary mucin had 
significant but much weaker activity. Among the sialogly- 
coproteins tested, glycophorin A exhibited by far potent 
ligand activity for scavenger receptors. This order of the 
inhibitory activity is not simply due to their sialic acid 
content because the content of sialic acid of these glyco- 
protein preparations was in the order of glycophorins 
B + C (30.1%), c~j-acid glycoprotein (25.7%), glycophorin 
A (17.4%) and bovine submaxillary mucin (16.6%). The 
activity of glycophorin A was dependent on its sialyl 
residues since hydrolysis of sialyl residues with neu- 
raminidase resulted in a decrease in the activity (Table 3, 
section A). When polypeptide of glycophorin A was di- 
gested with Pronase, the inhibitory activity was much 
decreased. Thus, polypeptide portion is necessary for the 
ligand activity of glycophorin A. 
Glycophorin A is a transmembrane glycoprotein having 
heavily sialylated saccharide chains at the N-terminal 
polypeptide region that is located on outer cell surface 
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Table 3 
Inhibition of the binding of ox-LDL-coated mouse erythrocytes to mouse 
peritoneal macrophages by glycophorin A, its glycopeptides, and sialic 
acid 
Sialoglycoprotein or Macrophage binding 
monosaccharide (% of control assay) 
None 100 
A. Sialoglycoprotein (mg/ml)  
Glycophorin A 0.1 16.1+ 8.4 
Glycophorins B + C 0.1 55.2 __. 6.6 
a i-Acid glycoprotein 0.1 80.6 + 14.5 
1.0 79.1+ 7.1 
0.1 73.8_+ 9.2 
1.0 58.2+ 12.9 
Glycophorin A (control) ~ 0.1 21.3 -+ 15.6 
(neuraminidase-treated) 0.1 68.2 _+ 23. l 
(pronase-digested) 0.1 90.9 + 16.2 
TI + T2 tryptic glycopeptides 
(control) b 0.5 20.9_+ 5.9 
(neuraminidase-treated) 0.5 41.6+ 9.6 
B. Monosaccharide (mM) 
D-Glucose 50 93.2_+ 3.6 
D-Galactose 50 97.3 _+ 12.5 
D-Mannose 50 99.2 + 20.3 
L-Fucose 50 101.7+ 5.1 
N-Acetyl-D-glucosamine 50 103.8 _+ 12.3 
N-Acetyl-o-galactosamine 50 96.1 _+ 2.5 
N-Acetylneuraminic a id ~ 50 16.9-+ 8.6 
Bovine submaxillary mucin 
A monolayer of mouse peritoneal macrophages was preincubated with the 
indicated concentrations of sialoglycoproteins or monosaccharides at 
37°C for 1 h, and then incubated with ox-LDL-coated mouse erythro- 
cytes at 37 ° C for 30 rain in the presence of the same concentrations of
the sialoglycoproteins or the monosaccharides. In the absence of the 
competitors (control assay, 'none' in the table), usually 30-45% of total 
macrophages bound ox-LDL-coated erythrocytes, and 2-3% bound native 
LDL-coated erythrocytes. Values given are the means + S.D. of triplicate 
coverslips. 
Processed similarly to the enzyme-treated glycophorin A without the 
enzyme. 
b Processed similarly to the neuraminidase-treated T1 +T2 tryptic gly- 
copeptides without he enzyme. 
c Solution neutralized. 
[47,48]. To minimize the effect of polypeptide portion, 
glycopeptide fragments of external cell surface containing 
most of sialosaccharide chains of the glycophorin A 
molecule were prepared by trypsinization of glycophorin A 
[43], and their inhibitory activity was measured. The mix- 
ture of tryptic fragments TI and T2 (39 and 31 N-terminal 
residues, respectively [43]) obtained (T1 + T2 tryptic gly- 
copeptides) effectively inhibited the binding of ox-LDL- 
coated erythrocytes to macrophages, although the potency 
was lower than that of the parent glycophorin A molecule 
(Table 3, section A). The inhibitory activity of the gly- 
copeptides was decreased on neuraminidase tr atment. 
Inhibitory activity of monosaccharides was tested (Ta- 
ble 3, section B). Among the monosaccharides tested, 
N-acetylneuraminic acid showed potent inhibitory activity. 
Hence, sialyl residues of glycophorin A is involved in the 
ligand activity of glycophorin A for scavenger receptors. 
Inhibitory effect of glycophorin A on the uptake and 
degradation of ox-LDL by mouse peritoneal macrophages 
was then investigated. 12SI-Labeled native LDL and ox- 
LDL were incubated with mouse peritoneal macrophages 
at 37°C for 5 h, and the TCA-soluble radioactivity re- 
leased into the medium during the incubation was mea- 
sured as an index for the uptake and degradation of the 
LDL by macrophages [46]. Degradation of 125I-ox-LDL 
was inhibited by the ligands for scavenger receptors (Table 
4, section A), and not by the non-lingands (Table 4, 
section B). Under the same conditions, glycophorin A 
effectively inhibited the degradation of 125I-ox-LDL by the 
macrophages, and glycophorins B + C weakly inhibited 
(Table 4, section C). Other glycoproteins, C~l-acid glyco- 
protein and fetuin, did not show the activity. In the inhibi- 
tion study using 20 mM of saccharides (Table 4, section 
D), N-acetylneuramin lactose showed potent inhibitory 
activity, but N-acetylneuraminic acid did not. The results 
indicate that, as well as the known ligands for scavenger 
receptors, glycophorin A inhibits the uptake and degrada- 
tion of ox-LDL by macrophages, and possibly its sialosac- 
charide chains are involved in the inhibitory activity. 
Table 4 
Inhibition by known ligands for scavenger receptors, glycophorin A, and 
sialyl lactose of the degradation of 1251-ox-LDL by mouse peritoneal 
macrophages 
Competitor 125 I-ox-LDL Degradation 
(% of control assay) 
None 100 
A. Ligand for scavenger receptors 
(mg/ml)  
Ox-LDL 0.1 ~ 36.6 + 3.1 
Maleyl-BSA 10 68.8 + 7.5 
Dextran sulfate 0.2 41.4+ 5.8 
Fucoidan 0.2 38.2 + 3.2 
Poly I 0.2 47.8 + 1.0 
B. Non-ligand for scaeenger receptors 
BSA 10 105.0+ 11.2 
Poly C 0.2 107.5 ± 11.1 
C. Sialoglycoprotein 
Glycophorin A 0.2 29.3_ 2.4 
Glycophorins B + C 0.2 71.3 + 7.5 
ot I -Acid glycoprotein 0.2 97.8 _ 3.1 
Fetuin 0.2 87.9 + 7.7 
D. Saccharide 
(mM) 
N-Acetylneuraminic a id b 20 119.5 + 13.9 
N-Acetylneuramin lactose b 20 29.4+ 9.8 
Lactose 20 87.9__+ 4.3 
A monolayer of mouse peritoneal macrophages was incubated with 
~25I-ox-LDL (I0 mg protein/ml) at 37 ° C for 5 h in the presence of the 
indicated concentrations of the ligands for scavenger receptors, sialogly- 
coproteins, and saccharides. Amount of 125I-ox-LDL taken up and de- 
graded by the macrophages was measured as the TCA-soluble radioactiv- 
ity in the medium. In the absence of the competitors (control assay, 
'none' in the table), usually the amount of degradation of t25I-ox-LDL 
was 3-5 /xg apoB/mg macrophage protein, and that of 125I-native LDL 
was 0.5-1 p,g apo B /mg macrophage protein. Values given are the 
means + S.D. of triplicate assays. 
Macrophage monolayer was preincubated with ox-LDL at 37 ° C for 2 h. 
b Solution neutralized. 
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Fig. 1. Binding of 125I-glycophorin A and 125I-T1 + T2 tryptic glycopep- 
tides to mouse peritoneal macrophages. (A) A monolayer of the 
macrophages was incubated with the indicated concentrations of 125I-gly- 
cophorin A (O)  or 125I-T1 +T2 tryptic glycopeptides (©) at 37°C for 2 
h. (B) A monolayer of the macrophages was incubated with 125I-glyco- 
phorin A (50 p,g/ml) at 37°C for the indicated period. After washing, 
the cells were lysed with 0.2 M NaOH, and the radioactivity of the lysate 
was counted. Each point represents he mean_+ S.D. of triplicate assays. 
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Fig. 2. Effect of various sialoglycoproteins on the binding of ~25I-glyco- 
phorin A to mouse peritoneal macrophages. A monolayer of the 
macrophages was incubated with J25I-glycophorin A (5 ~g/ml )  in the 
presence of the indicated concentrations of unlabeled glycophorin A (O), 
neuraminidase-treated glycophorin A (O), pronase-digested glycophorin 
A ( I ) ,  glycophorins B+C (El), ai-acid glycoprotein ( i )  and bovine 
submaxillary mucin (A)  at 37°C for 2 h. After washing, the cells were 
lysed with 0.2 M NaOH, and the radioactivity of the lysate was counted. 
Each point represents he mean + S.D. of triplicate assays. 
3.3. Binding of glycophorin A to the scavenger receptors 
of mouse peritoneal macrophages 
In order to obtain the direct evidence for the binding of 
glycophorin A to macrophages, the binding of 125I-glyco- 
phorin A and 125I-T1 + T2 tryptic glycopeptides to mouse 
peritoneal macrophages was investigated. The binding of 
the labeled glycophorin A to macrophages at37 ° C for 2 h 
increased with the concentration f the labeled glycophorin 
A and reached maximum of 0.5 pg/cell at the concentra- 
tion of 50 /~g/ml. Although the binding of the labeled 
tryptic glycopeptides was much lower, it increased with 
the concentration up to 100/zg/ml (Fig. 1A). Time course 
study of the binding of the labeled glycophorin A at 50 
/zg/ml reached maximum after 2 h (Fig. 1B). 
The binding of the labeled glycophorin A at 5 /zg/ml 
and 2 h was completely inhibited by 40-fold excess amount 
of unlabeled glycophorin A (Fig. 2), indicating that the 
binding of the labeled glycophorin A was specific. The 
inhibitory effect of the unlabeled glycophorin A was de- 
creased on treatment with neuraminidase and Pronase, 
although the activity was not completely lost (Fig. 2). The 
binding of glycophorin A to macrophages is likely to be 
dependent on both its sialyl residues and polypeptide 
portion. Glycoproteins such as glycophorins B + C, cq-acid 
glycoprotein and bovine submaxillary mucin did not show 
the inhibitory activity against he labeled glycophorin A
binding (Fig. 2). 
The binding of the labeled glycophorin A was effec- 
tively inhibited by the ligands for scavenger receptors, 
ox-LDL, maleyl-BSA, dextran sulfate, fucoidan and poly I 
(Table 5, section A), whereas the binding was little or not 
Table 5 
Inhibition of the binding of 125I-glycophorin A to mouse peritoneal 
macrophages by known ligands for scavenger receptors 
Competitor ]25I-Glycophorin A binding 
(% of control assay) 
None 100 
A. Ligand for scavenger receptors 
(mg/ml)  
Ox-LDL 0.1 7.9 + 1.4 
0,2 1.8-t- 1.1 
Maleyl-BSA 1.0 36.3 + 1.1 
Dextran sulfate 0.1 7.2 +__ 1.4 
Fucoidan 0.1 3.2 _ 0.8 
Poly I 0.1 2.4 _ 0.8 
B. Non-ligand for scavenger receptors 
LDL 0.1 88.5 _+ 6.8 
BSA 1.0 92.6 4- 2.4 
Poly C 0.1 89.8+0.3 
Colominic acid 0.1 101.2 + 2.4 
A monolayer of mouse peritoneal macrophages was incubated with 
J25I-glycophorin A (5 /zg/ml)  in the presence of the indicated concentra- 
tions of the competitors at 37 ° C for 2 h. After washing, the cells were 
lysed with 0.2 M NaOH, and the radioactivity of the lysate was counted. 
Values given are the means -I- S.D. of triplicate assays. 
a Solution neutralized. 
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inhibited by the non-ligands, LDL, BSA, poly C and 
colominic acid (Table 5, section B). 
4. Discussion 
In our previous papers, it has been shown that mouse 
erythrocytes oxidized with diamide [9,10], periodate [9,10] 
and ADP/Fe 3÷ [11,12] are recognized by mouse peri- 
toneal macrophages in the absence of opsonizing antibod- 
ies. It was shown that disulfide bond formation in mem- 
brane proteins is linked in part to generation of the recog- 
nition sites on the surface of the oxidized cells [9,10,12]. 
The recognition sites on the oxidized cells were elucidated 
to be sialosaccharide chains of the membrane glyco- 
proteins: glycophorin in the case of diamide- and perio- 
date-treated cells [10] and glycophorin and Band 3 glyco- 
protein in the case of ADP/Fe3+-treated cells [12], by the 
competitive inhibition studies using various glycoproteins 
and saccharides [10,12], and by prevention of the 
macrophage r cognition of the oxidized cells by enzymatic 
removal of cell surface sialyl residues or the glycosylated 
part of glycophorin [ 10]. AMthough periodate oxidizes ialyl 
residues to generate C7 or C8 analogues, the oxidized 
siaMyl residues of glycophorin were found to be still effec- 
tively recognized by the macrophages [ 10]. A macrophage 
receptor having affinity for siaMosaccharides was consid- 
ered to be involved in the recognition of the sialosaccha- 
rides of glycophorin on the surface of the oxidized cells. 
Sambrano et aM. [49] have recently reported that human 
erythrocytes oxidized with cupric ion/ascorbic acid or 
hydrogen peroxide, and in vitro aged human erythrocytes 
are bound and phagocytosed by mouse peritoneal 
macrophages through the scavenger receptor for ox-LDL. 
They [49] suggested that the determinants of the recogni- 
tion on the oxidized and in vitro aged cell surface are 
newly generated by reaction of membrane proteins with 
reactive aldehydes generated uring lipid peroxidation, as 
is the case for the recognition of ox-LDL by scavenger 
receptors [39,50-53], although they have not performed 
chemical analysis of the oxidized and in vitro aged cells. 
In the present study, it was found that binding of mouse 
erythrocytes oxidized with diamide, periodate and 
ADP/Fe 3+, and in vitro aged mouse erythrocytes to mouse 
peritoneal macrophages was inhibited effectively by the 
known ligands for scavenger receptors. This observation is 
consistent with that of Sambrano et aM. [49]. However, the 
present results as well as our previous findings [10,12] 
indicate that the determinants recognized on the oxidized 
and in vitro aged erythrocyte surface are sialosaccharide 
chains of gMycophorin, pos,sibly gMycophorin A counterpart 
of mouse erythrocytes, of the oxidized cells. 
In our experiments, it appears unlikely that adducts that 
might have been generated on membrane proteins by 
reaction with the products of lipid peroxidation are the 
determinants of the macrophage recognition because the 
conditions for the oxidation of mouse erythrocytes em- 
ployed in our study are mild, under which lipid peroxida- 
tion does not always take place. In diamide-treated cells, 
SH-oxidation occurs without accompanying lipid peroxida- 
tion [9,10]; in periodate-treated c lls, lipid peroxidation as 
well as SH-oxidation and oxidation of sialyl residues occur 
[44]; and in ADP/Fe3+-treated cells, lipid peroxidation 
and SH-oxidation occur slightly without accompanying 
physicochemical change of the cells [11]. Furthermore, 
treatment of the oxidized cells with dithiothreitol pre- 
vented the macrophage r cognition [9,12], suggesting that 
the determinants recognized by scavenger receptors are 
formed reversibly depending on SH-oxidation of the mem- 
brane proteins. 
It was clearly demonstrated here that isolated gly- 
cophorin A binds effectively to macrophages. Cross-inhibi- 
tion studies (inhibition of ox-LDL binding to macrophages 
by isolated glycophorin A; inhibition of uptake and degra- 
dation of ox-LDL by macrophages by isolated glycophorin 
A; and inhibition of isolated glycophorin A binding to 
macrophages by ox-LDL and other scavenger eceptor 
ligands) showed that isolated glycophorin A binds to 
macrophages through scavenger receptors. Sialyl residues 
of glycophorin A appear to play a critical role in the 
binding of glycophorin A to scavenger receptors because 
the inhibitory activity of glycophorin A against he binding 
of ox-LDL and glycophorin A to macrophages was 
markedly decreased on neuraminidase treatment. However, 
the observed strong ligand activity of glycophorin A can- 
not be accouted for merely by the content of sialic acid, 
i.e., intensity of negative charge of the molecule, because 
glycophorins B + C and al-acid glycoprotein with higher 
content of sialic acid showed the lower or no ligand 
activity, and much higher concentrations of N- 
acetylneuraminic a id or N-acetylneuramin lactose were 
required than that of the sialyl residues of glycophorin A
to inhibit the binding of ox-LDL. It has been suggested 
that the ligand activity of polyanions for scavenger recep- 
tors is not merely dependent on the negative charge of the 
molecules but on some specific spatial distribution of the 
negatively charged groups [22,24,29,54]. A dense and 
specific spatial distribution of sialyl residues that can be 
recognized by scavenger receptors may be formed in iso- 
lated glycophorin A. It is known that, in aqueous olution, 
isolated glycophorin A molecules aggregate to form parti- 
cles with molecular weight of about 400 kDa which corre- 
sponds to 10-12 glycophorin A molecules [42]. These 
particles are suggested to be formed by association within 
the hydrophobic domain (the membrane spanning domain), 
and the hydrophilic glycosylated portion is thought to 
extend from the center of the particle [42]. Thus, it is very 
likely that the negative charges of sialyl residues arranged 
on the surface of the aggregates serve a strong ligand for 
scavenger receptors. The observed ecrease in the ligand 
activity of glycophorin A and the considerably weaker 
ligand activity of T1 + T2 tryptic glycopeptides may be 
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due to destruction of the aggregates ororigomeric forms of 
glycophorin A by the proteolysis. 
Macrophages recognized the oxidized erythrocyes but 
not unoxidized cells [9,12] although glycophorin exists on 
both cells. Previously we suggested that oxidation of ery- 
throcytes may induce clustering of glycophorin molecules 
on the plane of the membrane, which results in locally 
increased ensity of the sialyl residues [10,12]. It is possi- 
ble that the cell surface clusters of glycophorin molecules 
form effective ligands for scavenger receptors as the gly- 
cophorin A aggregates in solution do. Clustering of gly- 
cophorin may be induced as a result of disulfide formation 
in the membrane proteins. We have shown in another 
study that human erythrocytes oxidized with diamide or 
ADP/Fe 3+ are recognized by anti-band 3 autoantibody in 
normal human plasma [55-57]. The antibody recognized 
sialylated saccharide chains of band 3 glycoprotein which 
underwent alterations in the membrane depending on SH- 
oxidation [55-57]. The alterations of the membrane glyco- 
proteins of the oxidized erythrocytes recognized by scav- 
enger eceptors and the autoantibody are likely to be based 
on common mechanism. 
In conclusion, it was suggested that mouse erythrocytes 
mildly oxidized with diamide, periodate and ADP/Fe 3+, 
and in vitro aged mouse erythrocytes bound to scavenger 
receptors of mouse peritoneal macrophages, and the lig- 
ands on the oxidized and in vitro aged erythrocytes for 
scavenger receptors were sialosaccharide chains of gly- 
cophorin. To our knowledge, this is the first example 
indicating that scavenger receptors recognize unmodified 
saccharide chains of cell surface glycoproteins. The 
physiological function of scavenger receptors is hypoth- 
esized to be the removal of a wide variety of oxidatively 
damaged or senescent components oeliminate the harmful 
effects of these components [58]. In addition to the recog- 
nition of chemically modified proteins [20,22,29], the pre- 
sent finding adds a new mechanism of the recognition of 
such damaged or senescent components by scavenger re- 
ceptors. 
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